Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of kidney smooth muscle cell differentiation. [GOC:obol]
Negative regulation of kidney smooth muscle cell differentiation involves a complex interplay of signaling pathways, transcription factors, and epigenetic modifications. It ensures proper development and function of the kidney by preventing premature or excessive differentiation of smooth muscle cells, which could lead to impaired blood flow and filtration. Key molecular mechanisms involved include:
1. **Growth factor signaling:** Transforming growth factor-beta (TGF-β) plays a crucial role in smooth muscle cell differentiation. Its suppression, through antagonists or inhibitory pathways, can negatively regulate this process. Other growth factors, like fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF), may also contribute to this regulation by influencing cell proliferation and differentiation.
2. **Transcription factors:** Specific transcription factors, such as myocardin, SRF, and MEF2, are essential for smooth muscle cell differentiation. Their expression and activity can be modulated by signaling pathways or epigenetic mechanisms to fine-tune the differentiation process. Negative regulation can involve inhibition of these factors or activation of opposing transcription factors.
3. **Epigenetic modifications:** Changes in DNA methylation, histone modifications, and non-coding RNA expression can influence gene expression and thereby regulate smooth muscle cell differentiation. This includes silencing of genes involved in differentiation or activating genes that promote an undifferentiated state.
4. **Microenvironment and cell-cell interactions:** The surrounding extracellular matrix and interactions with neighboring cells can significantly influence the differentiation of kidney smooth muscle cells. Factors like oxygen tension, mechanical stress, and interactions with other cell types can contribute to negative regulation by altering signaling pathways or influencing gene expression.
Understanding the intricate mechanisms of negative regulation of kidney smooth muscle cell differentiation is critical for elucidating developmental processes, identifying potential targets for treating kidney disease, and exploring therapeutic strategies for improving kidney health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sonic hedgehog protein | A sonic hedgehog protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15465] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
jervine | jervine: teratogen from Veratrum grandiflorum; RN given refers to parent cpd(3beta,23beta)-isomer; structure | piperidines | |
cyclopamine | piperidines | glioma-associated oncogene inhibitor | |
cur 61414 | CUR 61414: inhibits the hedehog signaling pathway; structure in first source | ||
gdc 0449 | HhAntag691: inhibits the hedgehog pathway and ABC transporters; has antineoplastic activity | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent |
robotnikinin | robotnikinin: binds sonic hedgehog protein to block its signaling pathway; structure in first source |